Selected Publications Birsen Can Demirdöğen. A literature review of biosensors for multiple sclerosis: towards personalized medicine and point-of-care testing. Multiple Sclerosis and Related Disorders. Available online 9 December 2020. Birsen Can Demirdöğen, Sinem Demirkaya-Budak, Gökhan Özge, Tarkan Mumcuoğlu. Evaluation of Tear Fluid and Aqueous Humor Concentration of Clusterin as Biomarkers for Early Diagnosis of Pseudoexfoliation Syndrome and Pseudoexfoliative Glaucoma. Curr Eye Res. 2020 Jul; 45(7):805-813. Birsen Can Demirdöğen, Canan Koçan-Akçin, Gökhan Özge, Tarkan Mumcuoğlu. Evaluation of tear and aqueous humor level, and genetic variants of connective tissue growth factor as biomarkers for early detection of pseudoexfoliation syndrome/glaucoma. Exp Eye Res. 2019 Dec;189:107837. Birsen Can Demirdöğen, Canan Koçan-Akçin, Ezgi Göksoy, Gizem Yakar, Tuğçe Öztepe, Sinem Demirkaya-Budak, Sinan Oflaz. Paraoxonase 1 (PON1) promoter (−107T/C) and coding region (192Q/R and 55L/M) genetic variations in pseudoexfoliation syndrome and pseudoexfoliative glaucoma risk. Graefe's Archive for Clinical and Experimental Ophthalmology. 2019 Oct;257(10):2257-2270. Birsen Can Demirdöğen. Potential role of calcifying nanoparticles in the etiology of multiple sclerosis. May 2019. Medical Hypotheses. 2019; Volume 128, Pages 25-27. Esra Bilgin, Birsen Can Demirdöğen, Aysun Türkanoğlu Özçelik, Şeref Demirkaya & Orhan Adalı. Association analysis of Glutathione S-transferase omega-1 and omega-2 genetic polymorphisms and ischemic stroke risk in a Turkish population. Neurological Research. 2019; 41(2):1-7. Aysun Türkanoğlu Özçelik, Tuğçe Öner, Birsen Can Demirdöğen, Semai Bek, Şeref Demirkaya, Orhan Adalı. Genetic polymorphisms of vitamin D3 metabolising CYP24A1 and CYP2R1 enzymes in Turkish patients with ischemic stroke. Neurological Research 2018; 40(5): 364-371.